Hepatitis C virus-positive patients on the waiting list for transplantation: Study, evaluation and treatment

Nephrology Dialysis Transplantation

Volumn 15, Issue SUPPL. 8, 2000, Pages 68-70

  Campistol, Josep M ^a,c   Esforzdo, Nuria ^a   Barrera, Josep M ^a   Morales, José M ^b   Oppenheimer, Frederic ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2B INTERFERON; ASPARTATE AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; RIBAVIRIN; VIRUS RNA;

ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HEMODIALYSIS; HEMOLYTIC ANEMIA; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; STANDARDIZATION; SURVIVAL; VIRUS REPLICATION;

EID: 0034486631     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.suppl_8.68     Document Type: Article

References (16)

1. Prevalence of hepatitis C virus infection in hemodialysis patients. A longitudinal study comparing the results of RNA and antibody assays
2. Cardiovascular mortality and morbidity in dialysis patients
3. Liver histology in chronic hemodialysis patients infected with hepatitis C virus
4. Liver disease in dialysis patients with antibodies to hepatitis C virus
5. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients
6. The impact of renal transplantation on survival in hepatitis C positive end-stage renal disease patients
7. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantations
8. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients
9. The impact of hepatitis C virus infection on renal allograft recipients
10. Interferon treatment for chronic hepatitis C virus infection in uremic patients
11. Interferon-2b treatment of chronic hepatitis C in haemodialysis patients
12. High rate of hepatitis C virus clearance in hemodialysis patients after interferon-therapy
13. Efficacy and tolerance of α-2b interferon therapy on HCV infection of hemodialyzed patients
14. Efficacy and tolerance of interferon-α (2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients: Pre- and post-renal transplantation assessment
15. Pharmacokinetics of α IFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: Clinical implications
16. Disease of the month: Transplantation in the patient with hepatitis C